A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.

NCT00386555 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was cancelled before patient enrollment

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: docetaxel
DRUG: CP-868,596 + docetaxel
DRUG: AG-013736 + docetaxel
DRUG: CP-868,596 + AG-013736 + docetaxel

Sponsor

Arog Pharmaceuticals, Inc.